Transgene Biotek Ltd Share Price

Q: What is the share price of Transgene Biotek Ltd today?

Transgene Biotek Ltd share price as on 18 Jul 2026 is ₹3.05

Healthcare

BSE: 526139 Small Cap ISIN: INE773D01018

As on 18 July 2026 at 06:23 IST

₹3.05

+ 0.08

(2.69%)

Sell Buy

Over 1 Month

-7.19%

Over 6 Months

9.19%

Over 1 Year

-28.95%

Over 3 Years

-28.43%

Transgene Biotek Ltd Summary

Close ₹2.97

Open ₹3.09

High ₹3.09

Low ₹2.92

Volume 13,778

Net Turnover (in Cr) ₹0.0041

52Wk High ₹5.26

52Wk Low ₹1.83

52Wk High / Low

1.83

5.26

Transgene Biotek Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹22.50

EPS (TTM) -

Book Value (BV) -1.21

Div. Yield -

P/E (TTM) -13.50

Price/Book Value -2.45

Delivery % 71.76 %

Face Value 10

Key Ratios

PE Ratio -

PB Ratio -

EV to Sales -

PEG Ratio -

ROA -

ROE -

Debt-Equity -

Net Profit Margin -

Operating Profit Margin -

Transgene Biotek Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1.04	0.42	0.23	0.30	0.44
Total Expenses	1.72	1.07	6.24	10.70	10.87
Profit Before Tax	-0.68	-0.66	-6.01	-10.40	-10.43
Profit After Tax	-0.68	-0.66	-6.01	-10.40	-10.43
Operating Profit After Depreciation	-0.43	-0.53	-5.83	-10.18	-10.17

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	9.83	8.22	8.32	13.26	23.19
Total Non Current Assets	142.83	141.22	141.31	146.40	156.23
Total Current Assets	1.26	1.11	1.04	0.70	0.65
Total Assets	144.09	142.33	142.36	147.10	156.88
Total Shareholder's Fund	10.03	10.71	11.37	17.38	22.24

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	1.20	-	-	0.10	0.01
Net Cash Used In Investing Activities	-1.70	-	-0.01	-0.10	-0.03
Net Cash Used In Financing Activities	0.78	-	-	-	-

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1.04	0.42	0.23	0.30	0.44
Total Expenses	1.72	1.07	6.24	10.70	10.87
Profit Before Tax	-0.68	-0.66	-6.01	-10.40	-10.43
Profit After Tax	-0.68	-0.66	-6.01	-10.40	-10.43
Operating Profit After Depreciation	-0.43	-0.53	-5.83	-10.18	-10.17

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	9.83	8.22	8.32	13.26	23.19
Total Non Current Assets	32.95	31.34	31.44	36.53	46.36
Total Current Assets	1.26	1.10	1.04	0.69	0.64
Total Assets	34.20	32.44	32.48	37.22	46.99
Total Shareholder's Fund	-7.55	-6.87	-6.21	-0.20	4.66

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	1.20	-	-	0.10	0.01
Net Cash Used In Investing Activities	-1.70	-	-0.01	-0.10	-0.04
Net Cash Used In Financing Activities	0.78	-	-	-	-

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	0.05	0.05	0.05	0.05	0.08
Total Expenses	0.33	0.10	0.13	0.19	0.62
Profit Before Tax	-0.46	-0.37	-0.39	-0.44	-0.71
Profit After Tax	-0.46	-0.37	-0.39	-0.43	-0.71
Operating Profit after Depreciation	-0.13	-0.05	-0.08	-0.14	-0.50

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	0.05	0.05	0.05	0.05	0.08
Total Expenses	0.33	0.10	0.13	0.19	0.62
Profit Before Tax	-0.46	-0.37	-0.39	-0.44	-0.71
Profit After Tax	-0.46	-0.37	-0.39	-0.43	-0.71
Operating Profit after Depreciation	-0.13	-0.05	-0.08	-0.14	-0.50

Transgene Biotek Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 2.90

S2 2.82

S3 2.73

Pivot 2.99

R1 3.07

R2 3.16

R3 3.24

Moving Average

20 SMA 3.10

50 SMA 2.90

100 SMA 2.68

200 SMA 3.17

Transgene Biotek Ltd Corporate Actions

No available data

AGM Date: 30 Sep 2021

AGM 30.09.2021 Proceedings of the 31st Annual General Meeting of the Company held on 30th September 2021 through video conferencing / other audio-visual means. (As Per BSE Announcement Dated on 9/30/2021 6:47:55 AM) Outcome of voting of 31st Annual General Meeting held on 30th September 2021.(As Per BSE Announcement Dated on 10/2/2021 10:56:07 AM)

AGM Date: 30 Sep 2022

This has reference to our letter dated 20th July 2022. At the meeting of the Board of Directors of the company held on 13th August 2022 the following decisions were taken: 1) It was decided to hold the 32nd Annual General Meting on Friday the 30th September 2022 at IST through Video-Conferencing (VC') / Other Audio-Visual Means ('OAVM') at 10.00 A.M. (IST). 2) The Register of Members and Share Transfer Books of the Company will remain closed from Monday the 26th September 2022 to Thursday the 29th September, 2022 (both days inclusive). Pursuant to Regulation 34(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Annual Report for the year ended 31st March, 2022 containing Notice of the 32nd Annual General Meeting scheduled to be held on Friday, 30th September, 2022 at 10.00 a.m. through Video Conference / Other Audio Visual Means (OAVM), in accordance, with various circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. The voting period begins on Tuesday, September 27, 2022 at 09.00 hrs and ends on Thursday, September 29, 2022 at 17.00 hrs. Kindly note that the soft copies of Annual Report containing Notice of 32nd Annual General Meeting is being uploaded on the website of Company at www.transgenebiotek.com (As Per BSE Announcement dated on 02.09.2022) OUTCOME OF AGM. Proceedings of the 32nd Annual General Meeting of the Company held on 30th September 2022 through video conferencing / other audio-visual means. (As Per BSE Announcement dated on 30.09.2022)

AGM Date: 30 Dec 2023

Outcome of Board Meeting 33rd Annual Report 2022-2023. Intimation of Book Closure. (As Per BSE Announcement Dated on 01.12.2023) AGM 30/12/2023 (As Per BSE Bulletin Dated on 01.12.2023) Proceedings of the 33rd Annual General Meeting of the Company held on 30th December 2023. Proceeding of the 33rd Annual General Meeting of the Company held on 30th December 2023. through video conferencing Proceedings of the 33rd Annual General Meeting of the Company held on 30th December 2023. (As Per BSE Announcement Dated on 30/12/2023) Outcome of voting Results of 33rd AGM and Scrutinizer ''s Report (As Per BSE Announcement dated on 01.01.2024)

AGM Date: 05 Dec 2024

AGM 05/12/2024 Outcome of Board Meeting. (As Per BSE Announcement Dated on 12.11.2024) Proceedings of the 34th AGM. Outcome of Voting of 34th AGM held on 05th December, 2024. At 10:00 AM. (As Per BSE Announcement Dated on 05.12.2024)

AGM Date: 30 Dec 2025

Decided to hold the 35th Annual General Meeting on Tuesday, December 30, 2025 at 11:00 A.M (IST) through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'). 35th Annual Report for the year ended 31st March, 2025 . (As per BSE Announcement dated on: 05.12.2025) Outcome of 35th AGM (As Per BSE Announcement Dated On : 29.12.2025)

Transgene Biotek Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Apollo Hospitals Enterprise Ltd	₹8,495.95	₹1,22,158.73
Max Healthcare Institute Ltd	₹1,008.95	₹98,195.43
Fortis Healthcare Ltd	₹988.95	₹74,661.59
Aster DM Healthcare Ltd	₹814.20	₹42,185.41
Narayana Hrudayalaya Ltd	₹1,861.80	₹38,047.89

Transgene Biotek Ltd Top Mutal Funds Invested

No data available

Transgene Biotek Ltd News

Transgene Biotek to hold board meeting

On 29 May 2026

15 May 2026, 06:43 pm

Transgene Biotek schedules board meeting

On 13 February 2026

29 Jan 2026, 11:04 am

Transgene Biotek schedules AGM

On 30 December 2025

17 Nov 2025, 04:44 pm

Transgene Biotek declare Quarterly Result

On 14 November 2025

31 Oct 2025, 04:20 pm

Transgene Biotek to announce Quarterly Result

On 7 August 2025

31 Jul 2025, 11:13 am

Transgene Biotek Ltd Stock Analysis

Annual revenue for Transgene Biotek Ltd increased by 150.05% to ₹1.04 crore in FY 2025 from ₹0.42 crore in FY 2024.
Annual Net Profit for Transgene Biotek Ltd increased by 3.14% to ₹-0.68 crore in FY 2025 from ₹-0.66 crore in FY 2024.
Promoter Shareholding in Transgene Biotek Ltd remains unchanged by 0.00% in the most recent quarter, from 21.68% in December 2025 to 21.68% in March 2026.
Transgene Biotek Ltd delivered a 1-year return of -28.95% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Transgene Biotek Ltd share price moved up by 2.69% from its previous close of INR ₹2.97. The latest Transgene Biotek Ltd share price is INR ₹3.05.
Transgene Biotek Ltd share price today has been at a low of 2.95 and a high of 3.08. Over the past 52 weeks, the Transgene Biotek Ltd share price has seen a low of 1.83 and a high of 5.26.